Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Tretinoin Cream 0.05% vs Retin-A in Acne Vulgaris
NCT03433378Phase 1Completed
- Start
- Aug 2017
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of tretinoin in acne vulgaris (3 arms). Primary endpoint: Demonstration of Bioequivalence at 12 weeks. Started Aug 2017; status: completed.
02
Drugs
tretinoin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT03433378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03433378.